FREE COMMUNICATION 6

 

15:15 - 16:45   HALL B

 

Free Communication Session 6 + Mini Lecture

 

CKD-MBD

 

Chairs: Ana Carina Ferreira, Lisbon, Portugal

            Michal Nowicki, Lodz, Poland

 

Mini lecture

 

The emerging role for bone alkaline phosphatase isoforms in chronic kidney disease - mineral

and bone disorder

Mathias Haarhaus, Stockholm, Sweden

 

FREE COMMUNICATIONS

 

SO028

CALCITRIOL SUPPLEMENTATION INCREASES VON WILLEBRAND FACTOR LEVELS, FIBROBLAST GROWTH FACTOR-23 LEVELS, AND VASCULAR CALCIFICATION SEVERITY IN EXPERIMENTAL CHRONIC KIDNEY DISEASE

Cynthia M. Pruss1, Bruno Svajger1, Jason G. E. Zelt1, Kimberly Laverty1, Emilie C. Ward1, Rachel M. Holden2, Michael A. Adams1, 1Queen’s Univ, Biomedical and Molecular Sciences, Kingston, ON, CANADA, 2Queen’s Univ, Medicine, Kingston, ON, CANADA.

 

SO029

A PHASE 1B/2A RANDOMISED, PLACEBO-CONTROLLED CLINICAL TRIAL WITH SNF472 IN HAEMODIALYSIS PATIENTS

Carolina Salcedo1, Joan Perelló1,2, Raquel Ojeda3, Pieter H. Joubert1, Marta Arias1, Ana Z. Canals1, Miguel D. Ferrer1, Vicens Torregrosa3, Josep M. Campistol3, Francesc Maduell3, 1Laboratoris Sanifit, R&D, Palma, SPAIN, 2Univ Balearic Islands, Lab Renal Lithiasis, Palma, SPAIN, 3Hosp Clínic, Nephrology & Renal Transplantation, Barcelona, SPAIN.

 

SO030

ONE YEAR EFFICACY AND SAFETY OF INTRAVENOUS (IV) ETELCALCETIDE (AMG 416) IN PATIENTS ON HEMODIALYSIS (HD) WITH SECONDARY HYPERPARATHYROIDISM (SHPT)

David A. Bushinsky1, Geoffrey A. Block2, Sunfa Cheng3, Hongjie Deng4, Pablo Ureña Torres5, Matrc Vervloet6, Glenn M. Chertow7, 1Univ Rochester, Nephrology, Rochester, NY, 2Denver Nephrology, Clinical Research, Denver, CO, 3Amgen, Nephrology, Thousand Oaks, CA, 4Amgen, Biostatistical Science, Thousand Oaks, CA, 5Clinique Landy, Serv Néphrologie-Dialyse, Saint Ouen, FRANCE, 6VU Univ Medical Center, Nephrology, Amsterdam, NETHERLANDS, 7Stanford Univ, Nephrology, Palo Alto, CA.

 

SO031

ASSOCIATIONS OF SINGLE NUCLEOTIDE POLYMORPHISM OF THE CALCIUM-SENSING RECEPTOR GENE (CASR RS7652589) WITH NEPHROLITHIASIS AND SECONDARY HYPERPARATHYROIDISM IN HEMODIALYSIS PATIENTS

Alicja Grzegorzewska1, Mateusz Paciorkowski2, Adrianna Mostowska3, Wojciech WarchoŁ4, PaweŁ JagodziŃski5, 1Poznan Univ Medical Sciences (PUMS), Dept Nephrology, Transplantology and Internal Diseases, Poznan, POLAND, 2Pleszew Medical Center, Dept Internal Diseases, Pleszew, POLAND, 3PUMS, Dept Biochemistry and Molecular Biology, Poznan, POLAND, 4PUMS, Dept Biophysics, Poznan, POLAND, 5PUMS, Dept Biochemistry and Molecular Biology, Poznan, POLAND.

 

SO032

BONE AND MINERAL STATUS ONE YEAR AFTER RENAL TRANSPLANTATION

Pieter Evenepoel1, Geert J. S. Behets2, Liesbeth Viaene3, Patrick C. D’Haese2, 1Catholic Univ Leuven,Nephrology, Leuven, BELGIUM, 2Univ Antwerp, Lab Pathophysiology, Wilrijk, BELGIUM, 3Catholic Univ Leuven, Neprhrology, Leuven, BELGIUM.

 

back to timetable

 

 

 

 

 

 

 

 

 

final programme "day by day" - may 21 - 24, 2016

today